ALTO INGREDIENTS INC (ALTO)
US0215131063 - Common Stock
We assign a fundamental rating of 2 out of 10 to ALTO. ALTO was compared to 84 industry peers in the Chemicals industry. ALTO has a bad profitability rating. Also its financial health evaluation is rather negative. ALTO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ALTO had negative earnings in the past year.
In the past year ALTO had a positive cash flow from operations.
ALTO had negative earnings in 4 of the past 5 years.
Of the past 5 years ALTO 4 years had a positive operating cash flow.
1.2 Ratios
ALTO's Return On Assets of -6.44% is on the low side compared to the rest of the industry. ALTO is outperformed by 82.14% of its industry peers.
With a Return On Equity value of -10.47%, ALTO is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.44% | ||
| ROE | -10.47% | ||
| ROIC | N/A |
ROA(3y)-2.1%
ROA(5y)-4.89%
ROE(3y)-3.86%
ROE(5y)-11.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALTO's Gross Margin of 1.28% is on the low side compared to the rest of the industry. ALTO is outperformed by 90.48% of its industry peers.
In the last couple of years the Gross Margin of ALTO has declined.
ALTO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.28% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.9%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALTO has been increased compared to 1 year ago.
Compared to 5 years ago, ALTO has more shares outstanding
The debt/assets ratio for ALTO is higher compared to a year ago.
2.2 Solvency
ALTO has an Altman-Z score of 0.99. This is a bad value and indicates that ALTO is not financially healthy and even has some risk of bankruptcy.
ALTO has a worse Altman-Z score (0.99) than 79.76% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that ALTO is not too dependend on debt financing.
The Debt to Equity ratio of ALTO (0.29) is better than 72.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.99 |
ROIC/WACCN/A
WACC9.17%
2.3 Liquidity
A Current Ratio of 2.59 indicates that ALTO has no problem at all paying its short term obligations.
ALTO has a better Current ratio (2.59) than 69.05% of its industry peers.
ALTO has a Quick Ratio of 1.78. This is a normal value and indicates that ALTO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALTO (1.78) is better than 72.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.78 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 35.00% over the past year.
Looking at the last year, ALTO shows a decrease in Revenue. The Revenue has decreased by -8.44% in the last year.
Measured over the past years, ALTO shows a decrease in Revenue. The Revenue has been decreasing by -4.20% on average per year.
EPS 1Y (TTM)35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q43.48%
Revenue 1Y (TTM)-8.44%
Revenue growth 3Y10.88%
Revenue growth 5Y-4.2%
Revenue growth Q2Q-16.68%
3.2 Future
ALTO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.25% yearly.
The Revenue is expected to grow by 2.01% on average over the next years.
EPS Next Y45.08%
EPS Next 2Y64.11%
EPS Next 3Y42.43%
EPS Next 5Y31.25%
Revenue Next Year-22.84%
Revenue Next 2Y-2.23%
Revenue Next 3Y3.56%
Revenue Next 5Y2.01%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ALTO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALTO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALTO indicates a slightly more expensive valuation: ALTO is more expensive than 78.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 32.23 |
4.3 Compensation for Growth
ALTO's earnings are expected to grow with 42.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.11%
EPS Next 3Y42.43%
5. Dividend
5.1 Amount
No dividends for ALTO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ALTO INGREDIENTS INC
NASDAQ:ALTO (4/29/2024, 7:00:00 PM)
After market: 1.93 -0.01 (-0.52%)1.94
0 (0%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap146.86M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.44% | ||
| ROE | -10.47% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.28% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.78 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y45.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.44%
Revenue growth 3Y10.88%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y